People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Bioheart CEO: Mike Tomas is named president and CEO of the cardiovascular cell technology treatment firm June 23. Tomas, who will also serve on Bioheart's board, has been president of the early-stage private equity firm and Bioheart investor The ASTRI Group for the past nine years. He will replace Karl Groth, who will remain chairman of the board. Bioheart is developing the catheter-based MyoCell cell therapy for heart failure patients and the MyoCath delivery system